MedTrace Logo

MRI-guided Focal Laser Ablation

NCT04379362 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2021-09-22

No results posted yet for this study

Summary

Magnetic resonance imaging-guided focal laser ablation of prostate cancer.

Conditions

Interventions

PROCEDURE

Focal laser ablation

Focal laser ablation

Sponsors & Collaborators

  • Biolitec

    collaborator UNKNOWN

  • Soteria Medical

    collaborator UNKNOWN

  • Siemens Corporation, Corporate Technology

    collaborator INDUSTRY

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Jurgen Fütterer, MD, PhD · Radboudumc Nijmegen

  • Michiel Sedelaar, MD, PhD · Radboudumc Nijmegen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
76 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-14
Primary Completion
2022-07-01
Completion
2024-07-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04379362 on ClinicalTrials.gov